These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 16367859

  • 1. Autogenous bone graft in conjunction with enamel matrix derivative in the treatment of deep periodontal intra-osseous defects: a report of 13 consecutively treated patients.
    Trombelli L, Annunziata M, Belardo S, Farina R, Scabbia A, Guida L.
    J Clin Periodontol; 2006 Jan; 33(1):69-75. PubMed ID: 16367859
    [Abstract] [Full Text] [Related]

  • 2. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S, Cakar G, Yildirim B, Sculean A.
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [Abstract] [Full Text] [Related]

  • 3. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
    Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C.
    J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
    [Abstract] [Full Text] [Related]

  • 4. A minimally invasive surgical technique with an enamel matrix derivative in the regenerative treatment of intra-bony defects: a novel approach to limit morbidity.
    Cortellini P, Tonetti MS.
    J Clin Periodontol; 2007 Jan; 34(1):87-93. PubMed ID: 17243998
    [Abstract] [Full Text] [Related]

  • 5. Single minimally invasive surgical technique with an enamel matrix derivative to treat multiple adjacent intra-bony defects: clinical outcomes and patient morbidity.
    Cortellini P, Nieri M, Prato GP, Tonetti MS.
    J Clin Periodontol; 2008 Jul; 35(7):605-13. PubMed ID: 18476997
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D, Scheyer ET, Mellonig JT.
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
    Trombelli L, Bottega S, Zucchelli G.
    J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
    [Abstract] [Full Text] [Related]

  • 11. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F, Arweiler NB, Szántó E, Agics A, Gera I, Sculean A.
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [Abstract] [Full Text] [Related]

  • 12. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ, Weinberg MA, Rosenberg E, Tarnow D.
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [Abstract] [Full Text] [Related]

  • 13. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F, Arweiler N, Húszár T, Gera I, Miron RJ, Sculean A.
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Hoidal MJ, Grimard BA, Mills MP, Schoolfield JD, Mellonig JT, Mealey BL.
    J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
    [Abstract] [Full Text] [Related]

  • 16. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A, Schwarz F, Chiantella GC, Donos N, Arweiler NB, Brecx M, Becker J.
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical performance of a regenerative strategy for intrabony defects: scientific evidence and clinical experience.
    Cortellini P, Tonetti MS.
    J Periodontol; 2005 Mar; 76(3):341-50. PubMed ID: 15857066
    [Abstract] [Full Text] [Related]

  • 19. Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall infrabony defects.
    Ogihara S, Wang HL.
    J Periodontol; 2010 Dec; 81(12):1734-42. PubMed ID: 20629545
    [Abstract] [Full Text] [Related]

  • 20. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
    Sculean A, Kiss A, Miliauskaite A, Schwarz F, Arweiler NB, Hannig M.
    J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.